PT Prodia Widyahusada Tbk (IDX:PRDA)

Market Cap	2.74T
Revenue (ttm)	2.25T
Net Income (ttm)	238.05B
Shares Out	937.50M
EPS (ttm)	253.92
PE Ratio	11.50
Forward PE	10.42
Dividend	172.93 (5.92%)
Ex-Dividend Date	May 8, 2025

Volume	490,000
Average Volume	677,220
Open	2,910.00
Previous Close	2,920.00
Day's Range	2,890.00 - 2,930.00
52-Week Range	2,410.00 - 3,680.00
Beta	-0.10
RSI	66.57
Earnings Date	Jul 28, 2025

About Bally's

PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia health care and specialty clinics; and offers vaccination services. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk operates as a subsidiary of PT Prodia Utama.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1973
• Employees: 2,962
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PRDA

Financial Performance

In 2024, PT Prodia Widyahusada Tbk's revenue was 2.25 trillion, an increase of 1.34% compared to the previous year's 2.22 trillion. Earnings were 270.20 billion, an increase of 3.97%.